Radiolabeled Compounds
Corsidus provides radiolabeling of drug candidate(s) for accelerator mass spectrometry (AMS) analysis of samples from human microdose studies. In the majority of cases inclusion of 14C-label as the reporter isotope will be sufficient for assessing the pharmacokinetic and ADME characteristics of the investigational drug.

Corsidus also provides the option of employing other radiolabeled isotopes that may be more informative depending on the chemical class and nature of the intended therapeutic. A decision on the incorporation of the most appropriate label would be made in consultation with the customer and guidance by our experienced AMS scientific review team.